FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014198295> ?p ?o ?g. }

• W2014198295 endingPage "403" @default.
• W2014198295 startingPage "394" @default.
• W2014198295 abstract "The use of vascular-endothelial growth factor (VEGF) antibody bevacizumab is associated with an increased risk of gastrointestinal (GI) perforation, but the incidence and risk of GI perforation associated with vascular endothelial growth factor tyrosine-kinase inhibitors (VEGFR-TKIs) has not been well described. We conduct a systematic review and meta-analysis of published trials to evaluate the overall incidence and risk of GI perforation associated with VEGFR-TKIs.Databases from PubMed, Web of Science and abstracts presented at ASCO meeting up to March 31, 2013 were searched to identify relevant studies. Eligible studies included prospective phase II and III trials evaluating VEGFR-TKIs in cancer patients with adequate data on GI perforation. Statistical analyses were conducted to calculate the summary incidence, odds ratio (OR) and 95% confidence intervals (CIs) by using either random effects or fixed effect models according to the heterogeneity of included studies.A total of 5352 patients with a variety of solid tumors from 20 clinical trials were included in our analysis. The incidence of GI perforation was 1.3% (95%CI: 0.8-2.0%) among patients receiving VEGFR-TKIs, with a mortality of 28.6% (15.0-47.6%). Patients treated with VEGFR-TKIs did not significantly increase the risk of GI perforation compared with patients treated with control medication, with an OR of 2.99 (95%CI: 0.85-10.53, p=0.089). Sub-group analysis showed that the incidence of GI perforation did not significantly vary with tumor types, VEGFR-TKIs and treatments regimens. No evidence of publication bias was observed.The use of VEGFR-TKIs dose not significantly increase the risk of GI perforation in comparison with the controls. Further studies are recommended to investigate this association and the risk differences among different tumor types, VEGFR-TKIs or treatment regimens." @default.
• W2014198295 created "2016-06-24" @default.
• W2014198295 creator A5003816686 @default.
• W2014198295 creator A5004597656 @default.
• W2014198295 creator A5035263099 @default.
• W2014198295 creator A5059865856 @default.
• W2014198295 creator A5089019392 @default.
• W2014198295 date "2014-03-01" @default.
• W2014198295 modified "2023-10-18" @default.
• W2014198295 title "Risk of gastrointestinal perforation in cancer patients treated with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A systematic review and meta-analysis" @default.
• W2014198295 cites W1539571840 @default.
• W2014198295 cites W1562056707 @default.
• W2014198295 cites W1572014797 @default.
• W2014198295 cites W1573363574 @default.
• W2014198295 cites W1947531983 @default.
• W2014198295 cites W1964435302 @default.
• W2014198295 cites W1966953116 @default.
• W2014198295 cites W1971837077 @default.
• W2014198295 cites W1974789470 @default.
• W2014198295 cites W1978139448 @default.
• W2014198295 cites W1984322002 @default.
• W2014198295 cites W1989675054 @default.
• W2014198295 cites W1996810564 @default.
• W2014198295 cites W1999966467 @default.
• W2014198295 cites W2000000541 @default.
• W2014198295 cites W2003278910 @default.
• W2014198295 cites W2012174693 @default.
• W2014198295 cites W2022254881 @default.
• W2014198295 cites W2023952988 @default.
• W2014198295 cites W2057550630 @default.
• W2014198295 cites W2076424556 @default.
• W2014198295 cites W2089902400 @default.
• W2014198295 cites W2095235698 @default.
• W2014198295 cites W2095796938 @default.
• W2014198295 cites W2096134439 @default.
• W2014198295 cites W2098499757 @default.
• W2014198295 cites W2101063853 @default.
• W2014198295 cites W2101776780 @default.
• W2014198295 cites W2104938382 @default.
• W2014198295 cites W2105464202 @default.
• W2014198295 cites W2107230638 @default.
• W2014198295 cites W2108923852 @default.
• W2014198295 cites W2109246013 @default.
• W2014198295 cites W2111053501 @default.
• W2014198295 cites W2114334138 @default.
• W2014198295 cites W2119501407 @default.
• W2014198295 cites W2121785313 @default.
• W2014198295 cites W2122132792 @default.
• W2014198295 cites W2126275851 @default.
• W2014198295 cites W2126621994 @default.
• W2014198295 cites W2126970264 @default.
• W2014198295 cites W2131754429 @default.
• W2014198295 cites W2132272301 @default.
• W2014198295 cites W2132648488 @default.
• W2014198295 cites W2133354058 @default.
• W2014198295 cites W2137508065 @default.
• W2014198295 cites W2144530818 @default.
• W2014198295 cites W2144575643 @default.
• W2014198295 cites W2149456801 @default.
• W2014198295 cites W2151261375 @default.
• W2014198295 cites W2152190103 @default.
• W2014198295 cites W2152756917 @default.
• W2014198295 cites W2153628956 @default.
• W2014198295 cites W2153966492 @default.
• W2014198295 cites W2155319477 @default.
• W2014198295 cites W2158474413 @default.
• W2014198295 cites W2158965678 @default.
• W2014198295 cites W2160888189 @default.
• W2014198295 cites W2161036119 @default.
• W2014198295 cites W2162424705 @default.
• W2014198295 cites W2170779902 @default.
• W2014198295 cites W2170952317 @default.
• W2014198295 cites W4236936143 @default.
• W2014198295 doi "https://doi.org/10.1016/j.critrevonc.2013.10.002" @default.
• W2014198295 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24182420" @default.
• W2014198295 hasPublicationYear "2014" @default.
• W2014198295 type Work @default.
• W2014198295 sameAs 2014198295 @default.
• W2014198295 citedByCount "57" @default.
• W2014198295 countsByYear W20141982952014 @default.
• W2014198295 countsByYear W20141982952015 @default.
• W2014198295 countsByYear W20141982952016 @default.
• W2014198295 countsByYear W20141982952017 @default.
• W2014198295 countsByYear W20141982952018 @default.
• W2014198295 countsByYear W20141982952019 @default.
• W2014198295 countsByYear W20141982952020 @default.
• W2014198295 countsByYear W20141982952021 @default.
• W2014198295 countsByYear W20141982952022 @default.
• W2014198295 countsByYear W20141982952023 @default.
• W2014198295 crossrefType "journal-article" @default.
• W2014198295 hasAuthorship W2014198295A5003816686 @default.
• W2014198295 hasAuthorship W2014198295A5004597656 @default.
• W2014198295 hasAuthorship W2014198295A5035263099 @default.
• W2014198295 hasAuthorship W2014198295A5059865856 @default.
• W2014198295 hasAuthorship W2014198295A5089019392 @default.
• W2014198295 hasConcept C120665830 @default.
• W2014198295 hasConcept C121332964 @default.
• W2014198295 hasConcept C126322002 @default.

• next